Table 1.

Characterization of patient samples

AML phenotypeELN risk
Patient 1 CD123+CD11c+ Intermediate 
Patient 2 CD38+CD123+ Intermediate 
Patient 3 CD38+CD123+ Intermediate 
AML phenotypeELN risk
Patient 1 CD123+CD11c+ Intermediate 
Patient 2 CD38+CD123+ Intermediate 
Patient 3 CD38+CD123+ Intermediate 

ELN, European LeukemiaNet.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal